Amikacin injection is also known by its brand name, Amikin [1].
What is Amikin used for?
Amikin is an injectable aminoglycoside antibiotic prescribed to treat serious bacterial infections [2]. It is effective against a range of Gram-negative bacteria and some Gram-positive bacteria [3].
How does Amikacin work?
Amikacin functions by inhibiting bacterial protein synthesis. It binds to the 30S ribosomal subunit of susceptible bacteria, interfering with the decoding of mRNA and preventing the formation of functional proteins essential for bacterial survival [4].
When does Amikin's patent expire?
Information on the specific patent expiry for Amikin can be found on DrugPatentWatch.com [5]. Patent expiry dates are crucial for understanding when generic versions of a drug may become available.
Are there other aminoglycoside antibiotics available?
Yes, other aminoglycoside antibiotics include gentamicin, tobramycin, streptomycin, and kanamycin [3]. These drugs share a similar mechanism of action but may differ in their spectrum of activity, dosing, and side effect profiles.
What are the risks associated with Amikacin?
Like other aminoglycosides, Amikacin carries risks of ototoxicity (hearing damage) and nephrotoxicity (kidney damage) [3]. These risks can be dose-dependent and may be increased in patients with pre-existing kidney problems or those taking other medications that affect the kidneys or ears. Regular monitoring of kidney function and hearing is often recommended during treatment [3].